GSK Investigational Site
Harrow, Middlesex HA1 3UJ
0 studies enrolling now · 9 studies all time
What they study most
Acute Coronary Syndrome, Asthma, Atherosclerosis, Atrial Fibrillation, Crohn's Disease, Fibrillation, Atrial, Menopausal and Female Climacteric States
Studies at this site
- A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug — Completed
- An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
- Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study) — Completed
- A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
- Open-Label Extension Study of GSK1605786A — Stopped early
- GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
- The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
- The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
- Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke — Completed